Eisai
4523.T
#1936
Rank
โ‚ฌ7.46 B
Marketcap
26,48ย โ‚ฌ
Share price
-0.23%
Change (1 day)
-33.99%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): 2,05ย โ‚ฌ

According to Eisai's latest financial reports the company's current EPS (TTM) is 2,01ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 1,48ย โ‚ฌ a decrease over its 2021 EPS that were of 6,56ย โ‚ฌ.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)2,05ย โ‚ฌ38.85%
20221,48ย โ‚ฌ-77.48%
20216,56ย โ‚ฌ-41.88%
202011,29ย โ‚ฌ-0.94%
201911,40ย โ‚ฌ52.59%
20187,47ย โ‚ฌ124.17%
20173,33ย โ‚ฌ-49.42%
20166,59ย โ‚ฌ37.08%
20154,81ย โ‚ฌ-11.75%
20145,45ย โ‚ฌ-3.23%
20135,63ย โ‚ฌ-18.56%
20126,91ย โ‚ฌ-15.51%
20118,18ย โ‚ฌ-3.75%
20108,50ย โ‚ฌ-1.36%
20098,61ย โ‚ฌ